Nevertheless, despite reduced Kv7.4 expression, Kv7 activators retain the ability to dilate pulmonary arteries in PAH [9,57,67] and may even be more effective [57]. The gene discussed is KCNQ4; the disease is pulmonary arterial hypertension.